Protective Effects of SGLT2 Inhibitor Luseogliflozin on Pancreatic Beta Cells in Obese Diabetic db/db Mice-"The Earlier and Longer, the Better"

被引：0
|
作者：
Kimura, Tomohiko
Shimoda, Masashi
Nakanishi, Shuhei
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-2111-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
    Yoshiro Fushimi
    Atsushi Obata
    Junpei Sanada
    Yuka Nogami
    Tomoko Ikeda
    Yuki Yamasaki
    Yoshiyuki Obata
    Masashi Shimoda
    Shuhei Nakanishi
    Tomoatsu Mune
    Kohei Kaku
    Hideaki Kaneto
    Scientific Reports, 11
  • [32] Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes
    Kimura, Tomohiko
    Kaneto, Hideaki
    Shimoda, Masashi
    Hirukawa, Hidenori
    Okauchi, Seizo
    Kohara, Kenji
    Hamamoto, Sumiko
    Tawaramoto, Kazuhito
    Hashiramoto, Mitsuru
    Kaku, Kohei
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 400 (0C) : 78 - 89
  • [33] The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice
    Mayoux, E.
    Klein, T.
    Grempler, R.
    Michael, M.
    Tahbaz, A.
    Naderali, E. K.
    DIABETIC MEDICINE, 2014, 31 : 66 - 66
  • [34] The SGLT2 inhibitor dapagliflozin preserves human beta cell function in diabetic mice
    Karlsson, D.
    Ahnmark, A.
    Andreasson, A-C
    Sabirsh, A.
    Linden, D.
    Winzell, M. Sorhede
    DIABETOLOGIA, 2017, 60 : S109 - S109
  • [35] Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice
    Inafuku, Masashi
    Nagao, Koji
    Nomura, Saori
    Shirouchi, Bungo
    Inoue, Nao
    Nagamori, Naoki
    Nakayama, Hideyuki
    Toda, Takayoshi
    Yanagita, Teruyoshi
    BRITISH JOURNAL OF NUTRITION, 2012, 107 (05) : 639 - 646
  • [36] Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8
    Takiyama, Yumi
    Sera, Toshihiro
    Nakamura, Masanori
    Ishizeki, Kanaki
    Saijo, Yasuaki
    Yanagimachi, Tsuyoshi
    Maeda, Manami
    Bessho, Ryoichi
    Takiyama, Takao
    Kitsunai, Hiroya
    Sakagami, Hidemitsu
    Fujishiro, Daisuke
    Fujita, Yukihiro
    Makino, Yuichi
    Abiko, Atsuko
    Hoshino, Masato
    Uesugi, Kentaro
    Yagi, Naoto
    Ota, Tsuguhito
    Haneda, Masakazu
    EBIOMEDICINE, 2018, 36 : 329 - 346
  • [37] Alterations of the Ca2+ signaling pathway in pancreatic beta-cells isolated from db/db mice
    Liang, Kuo
    Du, Wen
    Lu, Jingze
    Li, Fei
    Yang, Lu
    Xue, Yanhong
    Hille, Bertil
    Chen, Liangyi
    PROTEIN & CELL, 2014, 5 (10) : 783 - 794
  • [38] Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1
    Kohara, Kenji
    Obata, Atsushi
    Kimura, Tomohiko
    Shimoda, Masashi
    Moriuchi, Saeko
    Okauchi, Scizo
    Hirukawa, Hidenori
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    ENDOCRINE JOURNAL, 2019, 66 (01) : 43 - 50
  • [39] Quantitative proteomics study of protective effects of grape seed procyanidin B2 on diabetic cardiomyopathy in db/db mice
    Luan, Si-si
    Yu, Fei
    Li, Bao-ying
    Qin, Rui-jie
    Li, Xiao-li
    Cai, Qian
    Yin, Wen-bin
    Cheng, Mei
    Gao, Hai-qing
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2014, 78 (09) : 1577 - 1583
  • [40] Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice
    Tahara, Atsuo
    Takasu, Toshiyuki
    ENDOCRINE RESEARCH, 2020, 45 (02) : 147 - 161
12345